600 related articles for article (PubMed ID: 28585723)
1. Therapeutic Potential of Matrix Metalloproteinase Inhibition in Breast Cancer.
Radisky ES; Raeeszadeh-Sarmazdeh M; Radisky DC
J Cell Biochem; 2017 Nov; 118(11):3531-3548. PubMed ID: 28585723
[TBL] [Abstract][Full Text] [Related]
2. Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders.
Liu J; Khalil RA
Prog Mol Biol Transl Sci; 2017; 148():355-420. PubMed ID: 28662828
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer.
Radisky ES; Radisky DC
J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):201-12. PubMed ID: 20440544
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis.
Craig VJ; Zhang L; Hagood JS; Owen CA
Am J Respir Cell Mol Biol; 2015 Nov; 53(5):585-600. PubMed ID: 26121236
[TBL] [Abstract][Full Text] [Related]
5. Membrane-type matrix metalloproteases as diverse effectors of cancer progression.
Turunen SP; Tatti-Bugaeva O; Lehti K
Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1974-1988. PubMed ID: 28390905
[TBL] [Abstract][Full Text] [Related]
6. New approaches to selectively target cancer-associated matrix metalloproteinase activity.
Tauro M; McGuire J; Lynch CC
Cancer Metastasis Rev; 2014 Dec; 33(4):1043-57. PubMed ID: 25325988
[TBL] [Abstract][Full Text] [Related]
7. Matrix Metalloproteinases (MMPs) in Targeted Drug Delivery: Synthesis of a Potent and Highly Selective Inhibitor against Matrix Metalloproteinase- 7.
Wang LL; Zhang B; Zheng MH; Xie YZ; Wang CJ; Jin JY
Curr Top Med Chem; 2020; 20(27):2459-2471. PubMed ID: 32703131
[TBL] [Abstract][Full Text] [Related]
8. Roles of Matrix Metalloproteinases and Their Natural Inhibitors in Metabolism: Insights into Health and Disease.
Molière S; Jaulin A; Tomasetto CL; Dali-Youcef N
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445827
[TBL] [Abstract][Full Text] [Related]
9. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue.
Matsunaga Y; Koda M; Murawaki Y
Res Commun Mol Pathol Pharmacol; 2004; 115-116():143-50. PubMed ID: 17564313
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases and periodontal diseases.
Sapna G; Gokul S; Bagri-Manjrekar K
Oral Dis; 2014 Sep; 20(6):538-50. PubMed ID: 23849049
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinases and their inhibitors in bone: an overview of regulation and functions.
Varghese S
Front Biosci; 2006 Sep; 11():2949-66. PubMed ID: 16720367
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases in tumor invasion.
Johansson N; Ahonen M; Kähäri VM
Cell Mol Life Sci; 2000 Jan; 57(1):5-15. PubMed ID: 10949577
[TBL] [Abstract][Full Text] [Related]
13. Cobalt chloride-induced hypoxia modulates the invasive potential and matrix metalloproteinases of primary and metastatic breast cancer cells.
Fu OY; Hou MF; Yang SF; Huang SC; Lee WY
Anticancer Res; 2009 Aug; 29(8):3131-8. PubMed ID: 19661326
[TBL] [Abstract][Full Text] [Related]
14. Calcifying Cystic Odontogenic Tumour: immunohistochemical expression of matrix metalloproteinases, their inhibitors (TIMPs and RECK) and inducer (EMMPRIN).
Prosdócimi FC; Rodini CO; Sogayar MC; Sousa SC; Xavier FC; Paiva KB
J Oral Pathol Med; 2014 Aug; 43(7):545-53. PubMed ID: 24484176
[TBL] [Abstract][Full Text] [Related]
15. [The expression of MMPs and TIMPs in human breast cancer tissues and importance of their balance in cancer invasion and metastasis].
Iwata H; Kobayashi S; Iwase H; Okada Y
Nihon Rinsho; 1995 Jul; 53(7):1805-10. PubMed ID: 7630023
[TBL] [Abstract][Full Text] [Related]
16. Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.
Levin M; Udi Y; Solomonov I; Sagi I
Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1927-1939. PubMed ID: 28636874
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinases as breast cancer drivers and therapeutic targets.
Radisky ES; Radisky DC
Front Biosci (Landmark Ed); 2015 Jun; 20(7):1144-63. PubMed ID: 25961550
[TBL] [Abstract][Full Text] [Related]
18. [Expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in joint tissues of rapidly destructive coxarthropathy (RDC), analyzed by immunohistochemical study].
Matsumoto F; Uzuki M; Kaneko C; Rikimaru A; Kokubun S; Sawai T
Ryumachi; 1997 Oct; 37(5):688-95. PubMed ID: 9396371
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinases and their inhibitors.
Kugler A
Anticancer Res; 1999; 19(2C):1589-92. PubMed ID: 10365151
[TBL] [Abstract][Full Text] [Related]
20. Assay of matrix metalloproteases types 8 and 9 by ELISA in human breast cancer.
Duffy MJ; Blaser J; Duggan C; McDermott E; O'Higgins N; Fennelly JJ; Tschesche H
Br J Cancer; 1995 May; 71(5):1025-8. PubMed ID: 7734294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
